Follow Health Care Reform Insider on Twitter
You are here:  Home  >  Medicare  >  Current Article

CMS Moves on Biosimilar Reimbursement

January 29, 2016 

Although there are many parameters remaining to be defined for biosimilars, the Centers for Medicare & Medicaid Services (CMS) is actively working on defining its policies.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>